#AHA23
Late-Breaking Science
Daily Coverage
Industry Highlights
Photo Gallery
Program
AHA21
Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack
Experts will discuss reducing ischemic and bleeding risk with antiplatelet therapy in patients with CAD, and explain the evidence for DAPT in acute ischemic stroke/TIA and the need for its early use in appropriate individuals
AHA21
Member Connect
AHA21
Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells
AHA21
The latest science in heart failure
AHA21
Trials’ results highlight the potential for fish oil to fight COVID-19 and MK-0616 to lower cholesterol
AHA21
New drugs, indications in cardiovascular disease
Researchers present research regarding aspirin and dementia, early P2Y12 inhibitors, ticagrelor reversal agent and oral factor XIa.
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Sponsored
Guideline for the Management of Patients With Chronic Coronary Disease
Clinical update slides
AHA21
Valves, veins and new viewpoints in cardiothoracic surgery
Trials’ results shed light on a new device for extending vein graft durability, the timing of bypass surgery after Ticagrelor cessation and aortic valve replacement, and best practices for concomitant tricuspid valve repair.
Late-Breaking Science
LBS coverage (2020): AF trials reveal pragmatic screening and intervention opportunities